Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 4143

  • The following term was not found in PubMed: 2006;S63-66.
1.

Acute Peritoneal Dialysis System for Neonates with Acute Kidney Injury Requiring Renal Replacement Therapy: A Case Series.

Ao X, Zhong Y, Yu XH, Marshall MR, Feng T, Ning JP, Zhou QL.

Perit Dial Int. 2018 Dec;38(Suppl 2):S45-S52. doi: 10.3747/pdi.2018.00109. Epub 2018 Oct 12.

PMID:
30315044
2.

The Effect of Automated Versus Continuous Ambulatory Peritoneal Dialysis on Mortality Risk In China.

Li X, Xu H, Chen N, Ni Z, Chen M, Chen L, Dong J, Fang W, Yu Y, Yang X, Chen J, Yu X, Yao Q, Sloand JA, Marshall MR.

Perit Dial Int. 2018 Dec;38(Suppl 2):S25-S35. doi: 10.3747/pdi.2017.00235. Epub 2018 Oct 12.

PMID:
30315042
3.

Number of Daily Peritoneal Dialysis Exchanges and Mortality Risk in a Chinese Population.

Yu X, Chen J, Ni Z, Chen N, Chen M, Dong J, Chen L, Yu Y, Yang X, Fang W, Yao Q, Sloand JA, Marshall MR.

Perit Dial Int. 2018 Dec;38(Suppl 2):S53-S63. doi: 10.3747/pdi.2017.00283. Epub 2018 Oct 12.

PMID:
30315040
4.

Age at diagnosis and the surgical management of small renal carcinomas: findings from a cross-sectional population-based study.

White VM, Marco DJT, Bolton D, Papa N, Neale RE, Coory M, Davis ID, Wood S, Giles GG, Jordan SJ.

BJU Int. 2018 Nov;122 Suppl 5:50-61. doi: 10.1111/bju.14585.

5.

Rationale for treating hepatitis C virus infection in patients with mild to moderate chronic kidney disease.

Ridruejo E, Mendizabal M, Silva MO.

Hemodial Int. 2018 Apr;22 Suppl 1:S97-S103. doi: 10.1111/hdi.12651. Review.

PMID:
29694730
6.

Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis.

Rutledge SM, Chung RT, Sise ME.

Hemodial Int. 2018 Apr;22 Suppl 1:S81-S96. doi: 10.1111/hdi.12649. Review.

PMID:
29694729
7.

Rationale for treatment of hepatitis C virus infection in end-stage renal disease patients who are not kidney transplant candidates.

Al-Rabadi L, Box T, Singhania G, Al-Marji C, Agarwal A, Hall I, Gordon CE, Tran H.

Hemodial Int. 2018 Apr;22 Suppl 1:S45-S52. doi: 10.1111/hdi.12656. Review.

PMID:
29694728
8.

Treatment and management options for the hepatitis C virus infected kidney transplant candidate.

Dejman A, Ladino MA, Roth D.

Hemodial Int. 2018 Apr;22 Suppl 1:S36-S44. doi: 10.1111/hdi.12646. Review.

PMID:
29694726
9.

Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies.

Puchades Renau L, Berenguer M.

Hemodial Int. 2018 Apr;22 Suppl 1:S8-S21. doi: 10.1111/hdi.12647. Review.

PMID:
29694724
10.

Timing of hepatitis C virus infection treatment in kidney transplant candidates.

Cohen-Bucay A, Francis JM, Gordon CE.

Hemodial Int. 2018 Apr;22 Suppl 1:S61-S70. doi: 10.1111/hdi.12643. Review.

PMID:
29694723
11.

Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients.

Sise ME, Chute DF, Gustafson JL, Wojciechowski D, Elias N, Chung RT, Williams WW.

Hemodial Int. 2018 Apr;22 Suppl 1:S71-S80. doi: 10.1111/hdi.12650. Review.

PMID:
29694722
12.

Hepatitis C virus infection in kidney transplantation-changing paradigms with novel agents.

Reddy YNV, Nunes D, Chitalia V, Gordon CE, Francis JM.

Hemodial Int. 2018 Apr;22 Suppl 1:S53-S60. doi: 10.1111/hdi.12659. Review.

PMID:
29694721
13.

Pharmacokinetics and drug interactions of medications used to treat hepatitis C virus infection in the setting of chronic kidney disease and kidney transplantation.

Ortiz GA, Trivedi HD, Nader C.

Hemodial Int. 2018 Apr;22 Suppl 1:S22-S35. doi: 10.1111/hdi.12648. Review.

PMID:
29694720
14.

Infections complicating cirrhosis.

Piano S, Brocca A, Mareso S, Angeli P.

Liver Int. 2018 Feb;38 Suppl 1:126-133. doi: 10.1111/liv.13645. Review.

PMID:
29427501
15.

Treatment of hepatitis C: the use of the new pangenotypic direct-acting antivirals in "special populations".

Pol S, Parlati L.

Liver Int. 2018 Feb;38 Suppl 1:28-33. doi: 10.1111/liv.13626. Review.

PMID:
29427485
16.

Urothelial Dysfunction and Chronic Inflammation are Associated With Increased Bladder Sensation in Patients With Chronic Renal Insufficiency.

Cheng SF, Jiang YH, Kuo HC.

Int Neurourol J. 2018 Jan;22(Suppl 1):S46-54. doi: 10.5213/inj.1832814.407. Epub 2018 Jan 31.

17.

Biology of portal hypertension.

McConnell M, Iwakiri Y.

Hepatol Int. 2018 Feb;12(Suppl 1):11-23. doi: 10.1007/s12072-017-9826-x. Epub 2017 Oct 26. Review.

PMID:
29075990
18.

Anti-thrombotic therapy for atrial fibrillation in patients with chronic kidney disease: Current views.

Ghadban R, Flaker G, Katta N, Alpert MA.

Hemodial Int. 2017 Oct;21 Suppl 2:S47-S56. doi: 10.1111/hdi.12600. Review.

PMID:
29064182
19.
20.

Supplemental Content

Loading ...
Support Center